HRP20040163A2 - Single dose azithromycin for treating respiratory infections - Google Patents

Single dose azithromycin for treating respiratory infections

Info

Publication number
HRP20040163A2
HRP20040163A2 HR20040163A HRP20040163A HRP20040163A2 HR P20040163 A2 HRP20040163 A2 HR P20040163A2 HR 20040163 A HR20040163 A HR 20040163A HR P20040163 A HRP20040163 A HR P20040163A HR P20040163 A2 HRP20040163 A2 HR P20040163A2
Authority
HR
Croatia
Prior art keywords
single dose
respiratory infections
treating respiratory
dose azithromycin
azithromycin
Prior art date
Application number
HR20040163A
Other languages
English (en)
Inventor
William Dunne Michael
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of HRP20040163A2 publication Critical patent/HRP20040163A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HR20040163A 2001-08-21 2002-07-31 Single dose azithromycin for treating respiratory infections HRP20040163A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31386701P 2001-08-21 2001-08-21
PCT/IB2002/003076 WO2003018031A2 (fr) 2001-08-21 2002-07-31 Azithromycine unidose

Publications (1)

Publication Number Publication Date
HRP20040163A2 true HRP20040163A2 (en) 2005-02-28

Family

ID=23217490

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040163A HRP20040163A2 (en) 2001-08-21 2002-07-31 Single dose azithromycin for treating respiratory infections

Country Status (25)

Country Link
US (3) US20030148964A1 (fr)
EP (1) EP1418924A2 (fr)
JP (1) JP2005501862A (fr)
KR (1) KR20040032942A (fr)
AP (1) AP1729A (fr)
BG (1) BG108537A (fr)
BR (1) BR0211830A (fr)
CA (1) CA2458135A1 (fr)
CZ (1) CZ2004232A3 (fr)
EA (1) EA200400214A1 (fr)
EC (1) ECSP044985A (fr)
GE (1) GEP20063812B (fr)
HR (1) HRP20040163A2 (fr)
HU (1) HUP0401332A2 (fr)
IL (1) IL159585A0 (fr)
IS (1) IS7092A (fr)
MA (1) MA27059A1 (fr)
MX (1) MXPA04001605A (fr)
OA (1) OA12845A (fr)
PL (1) PL367888A1 (fr)
SK (1) SK1012004A3 (fr)
TN (1) TNSN04035A1 (fr)
WO (1) WO2003018031A2 (fr)
YU (1) YU8804A (fr)
ZA (1) ZA200400804B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005009447A1 (fr) * 2003-07-24 2005-02-03 Pliva - Research And Development Ltd. Dose unique a dissolution rapide d'azithromycine
US6984403B2 (en) 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CA2549225A1 (fr) 2003-12-04 2005-06-16 Pfizer Products Inc. Procede d'atomisation/congelation faisant appel a une extrudeuse pour la preparation de compositions medicamenteuses cristallines multiparticulaires contenant de preference un poloxamere et un glyceride
JP2007513145A (ja) 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 医薬用多微粒子の製造方法
JP2007513139A (ja) 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 安定性の改善した多粒子組成物
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
JP5324223B2 (ja) 2005-12-08 2013-10-23 トランセイブ, インク. 肺感染症を治療する抗感染薬の脂質ベースの組成物及びその使用法
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US20090005326A1 (en) * 2007-06-26 2009-01-01 Idexx Laboratories, Inc. Single dose roxithromycin
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
WO2009114810A2 (fr) * 2008-03-14 2009-09-17 The Florida International Uinversity Board Of Trustees Utilisation d'ellagitannines comme inhibiteurs de la détection du quorum bactérien
US20130156803A1 (en) 2011-06-04 2013-06-20 Rochester General Hospital Research Institute Compositions and methods related to p6
MX2015006681A (es) 2012-11-29 2016-04-06 Insmed Inc Formulaciones de vancomicina estabilizadas.
SMT202000516T1 (it) 2014-05-15 2020-11-10 Insmed Inc Metodi per trattamento di infezioni micobatteriche polmonati non tubercolari
WO2019191627A1 (fr) 2018-03-30 2019-10-03 Insmed Incorporated Procédés pour la fabrication continue de produits médicamenteux liposomaux
WO2019213398A1 (fr) 2018-05-02 2019-11-07 Insmed Incorporated Procédés de fabrication de formulations de médicament liposomal
WO2021163451A1 (fr) * 2020-02-14 2021-08-19 Asklepios Biopharmaceutical, Inc. Procédé de traitement d'une toxicité associée à une thérapie génique avec des antibiotiques

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US53264A (en) * 1866-03-20 Improved ditching-machine
SI7910768A8 (en) * 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RO107257B1 (ro) * 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
WO1989002271A1 (fr) * 1987-09-10 1989-03-23 Pfizer Azithromycine et derives utilises comme agents anti-protozoaires
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
TW271400B (fr) * 1992-07-30 1996-03-01 Pfizer
ES2104386T3 (es) * 1993-05-19 1997-10-01 Pfizer Compuesto intermedio para la acitromicina.
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
EP0758244B2 (fr) * 1994-05-06 2008-02-13 Pfizer Inc. Formes galeniques a liberation controlee de l'azithromycine
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US20040053264A1 (en) * 2002-02-01 2004-03-18 Park Sung Sup Clinical panel assay using DNA chips

Also Published As

Publication number Publication date
IS7092A (is) 2003-12-23
EP1418924A2 (fr) 2004-05-19
US20040023898A1 (en) 2004-02-05
ECSP044985A (es) 2004-04-28
JP2005501862A (ja) 2005-01-20
WO2003018031A3 (fr) 2003-10-02
MA27059A1 (fr) 2004-12-20
US7067493B2 (en) 2006-06-27
AP2004002968A0 (en) 2004-03-31
EA200400214A1 (ru) 2004-06-24
HUP0401332A2 (hu) 2004-11-29
IL159585A0 (en) 2004-06-01
MXPA04001605A (es) 2004-07-08
OA12845A (en) 2006-09-15
SK1012004A3 (sk) 2005-04-01
US20030148964A1 (en) 2003-08-07
ZA200400804B (en) 2005-05-03
CA2458135A1 (fr) 2003-03-06
AP1729A (en) 2007-03-26
WO2003018031A2 (fr) 2003-03-06
CZ2004232A3 (cs) 2005-10-12
GEP20063812B (en) 2006-05-10
YU8804A (sh) 2006-08-17
US6987093B2 (en) 2006-01-17
BG108537A (bg) 2005-02-28
PL367888A1 (en) 2005-03-07
BR0211830A (pt) 2004-09-08
KR20040032942A (ko) 2004-04-17
US20050250712A1 (en) 2005-11-10
TNSN04035A1 (fr) 2006-06-01

Similar Documents

Publication Publication Date Title
IL159585A0 (en) Single dose azithromycin for treating respiratory infections
GB0123951D0 (en) Therapies for treating respiratory diseases
GB2371462B (en) Radiation treatment system
IL161405A0 (en) Substituted diphenyl heterocycles useful, for treating hcv infection
AU4579401A (en) Lung treatment apparatus
IL165891A0 (en) 2' and 3'-nucleoside prodrugs for treating flaviviridae infections
AU2002360251A8 (en) Medical devices comprising nanocomposites
AU2002342613A8 (en) Treatment for wounds
AU151997S (en) Respiratory mask
AU1646701A (en) Composition for treating respiratory tract infections
GB2372947B (en) Air treatment unit
HUP0202396A3 (en) Medicaments useful for treating fractures
GB0127384D0 (en) Well treatment system
IL143549A0 (en) A system for veterinary treatment
GB2374662B (en) Air treatment system
GB2397018B (en) Combination therapy for treating disease
GB0112084D0 (en) The treatment of respiratory infections
GB0128004D0 (en) System for treatment
AU2002320308A1 (en) Drugs for treating viral infections
GB0130694D0 (en) Treatment
GB0102559D0 (en) Treatment for angiogenesis-dependant condition
SI1341542T1 (sl) Indanilni derivati za zdravljenje bolezni dihalnih poti
CA93370S (en) Inhaler
CA93371S (en) Inhaler
GB0015684D0 (en) Air treatment system

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20080707

Year of fee payment: 7

OBST Application withdrawn